Ventripoint Seeks TSXV Approval to Extend $0.10 Unit Financing

Ventripoint will seek approval to extend its non-brokered offering of up to 3.5 million units at $0.10 each. Each unit includes a warrant exercisable at $0.14 for 24 months. The first tranche closed Sept. 8, 2026; securities carry a four-month-and-one-day hold.